Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             89 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Advances in lung imaging techniques for the treatment of respiratory disease Möller, Winfried
 2008
 2 p. 87-92
6 p.
 artikel
2 Advances in modeling and in the treatment of respiratory disease Braddock, Martin
 2008
 2 p. 79-80
2 p.
 artikel
3 Airway epithelial cells – therapeutic targets for the treatment of COPD Farkas, Laszlo
 2008
 2 p. 111-117
7 p.
 artikel
4 AMP-activated protein kinase and malonyl-CoA: Targets for treating insulin resistance? Ye, Ji-Ming
 2005
 2 p. 157-163
7 p.
 artikel
5 AMP-activated protein kinase as a therapeutic target for diabetes Leff, Todd
 2007
 2 p. 123-127
5 p.
 artikel
6 A new paradigm for testing AD drugs – neuroimaging biomarkers as surrogate outcomes homologous in animals and humans Marizzoni, Moira
 2013
 2 p. e63-e71
nvt p.
 artikel
7 Animal models for Alzheimer's disease – the industry perspective Czech, Christian
 2013
 2 p. e73-e78
nvt p.
 artikel
8 Beta-cell replacement technologies: the potential of stem cells Jones, Peter M.
 2004
 2 p. 213-217
5 p.
 artikel
9 Beyond interferon and ribavirin: Antiviral therapies for hepatitis C virus Kwong, Ann D.
 2006
 2 p. 211-220
10 p.
 artikel
10 Biomarker utility in Alzheimer's disease clinical trials Soares, Holly D.
 2013
 2 p. e55-e62
nvt p.
 artikel
11 Can efflux inhibitors really counter resistance? Poole, Keith
 2006
 2 p. 145-152
8 p.
 artikel
12 Can phenotypic pathway signatures improve the prediction of response to PI3K pathway inhibitors? Watters, James W.
 2009
 2 p. 57-62
6 p.
 artikel
13 Cholesterol ester transfer protein (CETP) and atherosclerosis Polk, Donna
 2007
 2 p. 137-145
9 p.
 artikel
14 Cholesteryl ester transfer protein inhibition and the treatment of metabolic syndrome Clark, Ronald W.
 2005
 2 p. 117-124
8 p.
 artikel
15 Contents 2009
 2 p. i-
1 p.
 artikel
16 Contents 2006
 2 p. i-ii
nvt p.
 artikel
17 Contents 2004
 2 p. i-ii
nvt p.
 artikel
18 Contents 2007
 2 p. i-
1 p.
 artikel
19 Contents 2013
 2 p. i-
1 p.
 artikel
20 Contents 2005
 2 p. i-
1 p.
 artikel
21 Contents 2008
 2 p. i-
1 p.
 artikel
22 Control of obesity through the regulation of appetite Harrold, Joanne
 2004
 2 p. 219-225
7 p.
 artikel
23 Cortical network oscillations in Alzheimer's disease: insights from rodent models LeBeau, Fiona E.N.
 2013
 2 p. e79-e83
nvt p.
 artikel
24 Dipeptidyl peptidase IV inhibitors for type 2 diabetes and metabolic syndrome Wiedeman, Paul E.
 2005
 2 p. 143-149
7 p.
 artikel
25 Drug therapies for uterine fibroids: a new approach to an old problem Nowak, Romana A.
 2004
 2 p. 237-242
6 p.
 artikel
26 Drug therapy for the cardiac complications of diabetes Connelly, Kim
 2004
 2 p. 195-200
6 p.
 artikel
27 Editorial 2005
 2 p. iii-v
nvt p.
 artikel
28 Endoplasmic reticulum stress and the c-Jun N-terminal kinase pathway in insulin resistance Kaneto, Hideaki
 2005
 2 p. 111-116
6 p.
 artikel
29 Enhancement or prolongation of GLP-1 activity as a strategy for treatment of type 2 diabetes Ahrén, Bo
 2004
 2 p. 207-212
6 p.
 artikel
30 Epigenetic approaches to cancer therapy Pollock, Roy M.
 2009
 2 p. 71-79
9 p.
 artikel
31 Eradication of MRSA nasal colonization as a strategy for infection prevention Critchley, Ian A.
 2006
 2 p. 189-195
7 p.
 artikel
32 Estrogen-related receptor α (ERRα): A novel target in type 2 diabetes Handschin, Christoph
 2005
 2 p. 151-156
6 p.
 artikel
33 Extending the life of β-lactam antibiotics: New β-lactamase inhibitors Coleman, Ken
 2006
 2 p. 183-188
6 p.
 artikel
34 Fatty acid modulators for the treatment of diabesity Wertheimer, Stanley J.
 2007
 2 p. 129-135
7 p.
 artikel
35 From a cell's viewpoint: targeting mitochondria in Alzheimer's disease Carlson, Emily Ann
 2013
 2 p. e91-e98
nvt p.
 artikel
36 Fructose-1,6-bisphosphatase as a therapeutic target for type 2 diabetes van Poelje, Paul D.
 2007
 2 p. 103-109
7 p.
 artikel
37 Glucocorticoid antagonists and 11β-HSD1 inhibitors Wang, Minghan
 2007
 2 p. 117-122
6 p.
 artikel
38 Glucokinase activation–a strategy for T2D therapy: recent developments Sarabu, Ramakanth
 2007
 2 p. 111-115
5 p.
 artikel
39 Gut hormones regulating appetite and metabolism McGowan, Barbara M.
 2007
 2 p. 147-151
5 p.
 artikel
40 Heme detoxification and antimalarial drugs – Known mechanisms and future prospects Rathore, Dharmendar
 2006
 2 p. 153-158
6 p.
 artikel
41 Hepatitis C vaccines Martin, Perrine
 2006
 2 p. 203-209
7 p.
 artikel
42 HMG-coA reductase inhibitors: lipid-lowering and beyond Lutgens, Esther
 2004
 2 p. 189-194
6 p.
 artikel
43 11β-Hydroxysteroid dehydrogenase type 1 as a therapeutic target in the metabolic syndrome Tomlinson, Jeremy W.
 2005
 2 p. 93-96
4 p.
 artikel
44 Intestinal absorption inhibitors for type 2 diabetes mellitus: prevention and treatment Cheng, Alice Y.Y.
 2004
 2 p. 201-206
6 p.
 artikel
45 Is there a need for novel antihypertensive therapies? Waring, W Stephen
 2004
 2 p. 143-148
6 p.
 artikel
46 Latest therapies targeting exacerbations in COPD Taylor, John D.
 2008
 2 p. 101-110
10 p.
 artikel
47 Ligands to peroxisome proliferator-activated receptors as therapeutic options for metabolic syndrome Liu, Yanfang
 2005
 2 p. 165-169
5 p.
 artikel
48 LXR: A nuclear receptor target for cardiovascular disease? Bradley, Michelle N.
 2005
 2 p. 97-103
7 p.
 artikel
49 Malaria vaccines: New hope in old ideas Pinzon-Charry, Alberto
 2006
 2 p. 167-172
6 p.
 artikel
50 Meningococcal diseases: From genomes to vaccines Serino, Laura
 2006
 2 p. 129-136
8 p.
 artikel
51 Metabolic/endocrine system Sarabu, Ramakanth
 2007
 2 p. 101-102
2 p.
 artikel
52 Molecularly targeted cancer therapy Copeland, Robert A.
 2009
 2 p. 45-46
2 p.
 artikel
53 mTOR mediated anti-cancer drug discovery Liu, Qingsong
 2009
 2 p. 47-55
9 p.
 artikel
54 New anti-inflammatory therapies for the treatment of COPD Molfino, Nestor A.
 2008
 2 p. 93-96
4 p.
 artikel
55 New approaches to reduce the burden of RSV infection Mejías, Asunción
 2006
 2 p. 173-181
9 p.
 artikel
56 New breath for rotavirus vaccines Parashar, Umesh D.
 2006
 2 p. 159-165
7 p.
 artikel
57 New tuberculosis vaccines approaching clinical trial – An overview Nasser Eddine, Ali
 2006
 2 p. 113-119
7 p.
 artikel
58 Novel receptor antagonists for cancer therapy: hedgehog pathway inhibitors Shelton, Christopher A.
 2009
 2 p. 63-69
7 p.
 artikel
59 Novel targets for the treatment of obesity: a review of progress Cheetham, Sharon C.
 2004
 2 p. 227-235
9 p.
 artikel
60 Novel therapeutic strategies for the treatment of erectile dysfunction Hafron, Jason
 2004
 2 p. 249-257
9 p.
 artikel
61 Nuclear receptors: novel therapeutic targets for the treatment and prevention of atherosclerosis Hanniman, Elyisha A.
 2004
 2 p. 155-161
7 p.
 artikel
62 Overcoming the problem of chronic hepatitis B Fung, James
 2006
 2 p. 197-202
6 p.
 artikel
63 p38 MAP kinase as a therapeutic target in cardiovascular disease See, F.
 2004
 2 p. 149-154
6 p.
 artikel
64 Progress in antifungal therapy: Echinocandins versus azoles Nailor, Michael D.
 2006
 2 p. 221-226
6 p.
 artikel
65 Recent advances in the treatment of Alzheimers’: therapeutic strategies Richardson, Jill C.
 2013
 2 p. e51-e53
nvt p.
 artikel
66 Resting state EEG rhythms as network disease markers for drug discovery in Alzheimer's disease Babiloni, Claudio
 2013
 2 p. e85-e90
nvt p.
 artikel
67 RNAi-based treatment of HIV/AIDS: Current status and perspectives Vandekerckhove, Linos
 2006
 2 p. 227-235
9 p.
 artikel
68 Role of opiates and their receptors in the regulation of food intake and body weight Hadcock, John R.
 2005
 2 p. 171-175
5 p.
 artikel
69 Selective thyroid hormone agonists: A strategy for treating metabolic syndrome Grover, Gary J.
 2005
 2 p. 137-142
6 p.
 artikel
70 Stearoyl-CoA desaturase: A therapeutic target of insulin resistance and diabetes Dobrzyn, Agnieszka
 2005
 2 p. 125-128
4 p.
 artikel
71 Synaptic function as a preclinical and experimental medicine readout for disease-modifying therapy in Alzheimer's Disease Lu, Bai
 2013
 2 p. e99-e104
nvt p.
 artikel
72 Targeting fibrosis in respiratory lung disease Froese, A.R.
 2008
 2 p. 97-100
4 p.
 artikel
73 Targeting protein kinase C epsilon or theta as a therapeutic strategy for insulin resistance Schmitz-Peiffer, Carsten
 2005
 2 p. 105-110
6 p.
 artikel
74 Targeting the immune response in asthma Leishman, Andrew J.
 2008
 2 p. 119-124
6 p.
 artikel
75 Therapeutic approaches for the modification of high-density lipoproteins von Eckardstein, Arnold
 2004
 2 p. 177-187
11 p.
 artikel
76 Therapeutic strategies for benign prostatic hypertrophy Hieble, J. Paul
 2004
 2 p. 243-248
6 p.
 artikel
77 Therapeutic strategies for drug treatment of stress urinary incontinence Andersson, K-E.
 2004
 2 p. 259-265
7 p.
 artikel
78 Therapeutic strategies for infectious diseases: Vaccines and anti-infective agents Lambert, Paul-Henri
 2006
 2 p. 111-112
2 p.
 artikel
79 Therapeutic strategies for targeting PTP1B in diabetes Montalibet, Jacqueline
 2005
 2 p. 129-135
7 p.
 artikel
80 Therapeutic strategies for the treatment of dyslipidemia Dunbar, Richard L.
 2004
 2 p. 169-176
8 p.
 artikel
81 Therapeutic strategies for urge urinary incontinence Steers, William D.
 2004
 2 p. 267-273
7 p.
 artikel
82 Therapy interactions in chronic heart failure: synergies and asynergies of medication and device interventions Adamson, Philip B.
 2004
 2 p. 135-141
7 p.
 artikel
83 The use of small animal imaging in respiratory disease drug discovery Ask, K.
 2008
 2 p. 81-85
5 p.
 artikel
84 Tigecycline: First class glycylcycline Jones, C. Hal
 2006
 2 p. 137-144
8 p.
 artikel
85 Urocortin in cardiovascular disease: pathophysiology and therapeutic potential Khan, Sohail Q.
 2004
 2 p. 163-168
6 p.
 artikel
86 Vaccines for otitis media and other pediatric pneumococcal diseases Malinoski, Frank J.
 2006
 2 p. 121-127
7 p.
 artikel
87 Vascular inflammation and atherogenesis are activated via receptors for PAMPs and suppressed by regulatory T cells Yang, Xiao-Feng
 2008
 2 p. 125-142
18 p.
 artikel
88 Why do we not have a vaccine against congenital cytomegalovirus (CMV) infection? Schleiss, Mark R.
 2006
 2 p. 243-250
8 p.
 artikel
89 Zoster vaccine for the elderly Michalik, David E.
 2006
 2 p. 237-241
5 p.
 artikel
                             89 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland